S100A10 and breast carcinoma: Specifically, S100A10 in a heterotetramer with Annexin II can act as co-receptor for tPA, plasminogen and pro-cathepsin B to promote invasion and metastasis in breast carcinoma and glioma cells, but it can also affect macrophage invasion and breast cancer cell proliferation [144].